{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-021186","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.943987+00:00","generated_at":"2026-06-05T00:02:14.793184+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Estrella Immunopharma details $1M share repurchase: open market buys via 10b5-1 plan over 12 months","bullets":["Board authorized up to $1,000,000 in common stock repurchases (first announced Jan 30, 2024).","Repurchases expected via open market trades at prevailing prices under a Rule 10b5-1 plan.","Company will use existing cash reserves; plan may be modified or terminated based on market conditions.","Expected to occur within the next 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-021186","json":"https://secwatch.observer/filing/0001213900-24-021186.json","markdown":"https://secwatch.observer/filing/0001213900-24-021186.md","text":"https://secwatch.observer/filing/0001213900-24-021186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/0001213900-24-021186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/ea0201472-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T00:02:14.793184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}